Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subramanian Hariharan

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|April 15, 2008
Cardiotoxicity associated with sunitinibSubramanian Hariharan, Simon Lowry
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2022
Reply to S. Tan et alBrian I Rini, Javid J Moslehi, Subramanian Hariharan
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 8, 2005
Metastatic lung cancer in the cerebellopontine angles mimicking bilateral acoustic neuromaSubramanian Hariharan, Jianhua Zhu, Mangala A Nadkarni, et al.
Clinical Genitourinary Cancer|January 13, 2018
Anti-Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future DevelopmentThomas Powles, Andrea Necchi, Galit Rosen, et al.
Journal of the Neurological Sciences|May 27, 2006
Clinicopathologic and genetic analysis of siblings with NF1 and adult-onset gliomasSubramanian Hariharan, John E Donahue, Cecial Garre, et al.
Cerebrovascular Diseases (Basel, Switzerland)|January 7, 2004
Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke?Pinky Agarwal, Sanjeev Kumar, Subramanian Hariharan, et al.
Current Medical Research and Opinion|July 13, 2016
The effect of information on preferences for treatments of metastatic renal cell carcinomaCarol Mansfield, Sandy Srinivas, Connie Chen, et al.
Journal of Neurosurgery|August 21, 2002
Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningiomaWarren P Mason, Fred Gentili, David R Macdonald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2013
Randomized phase III trial of temsirolimus and bevacizumab versus interferon alfa and bevacizumab in metastatic renal cell carcinoma: INTORACT trialBrian I Rini, Joaquim Bellmunt, Jill Clancy, et al.
Oncoimmunology|November 11, 2017
Immune evasion mechanisms and immune checkpoint inhibition in advanced merkel cell carcinomaDirk Schadendorf, Paul Nghiem, Shailender Bhatia, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|April 15, 2008
Cardiotoxicity associated with sunitinibSubramanian Hariharan, Simon Lowry
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2022
Reply to S. Tan et alBrian I Rini, Javid J Moslehi, Subramanian Hariharan
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 8, 2005
Metastatic lung cancer in the cerebellopontine angles mimicking bilateral acoustic neuromaSubramanian Hariharan, Jianhua Zhu, Mangala A Nadkarni, et al.
Clinical Genitourinary Cancer|January 13, 2018
Anti-Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future DevelopmentThomas Powles, Andrea Necchi, Galit Rosen, et al.
Journal of the Neurological Sciences|May 27, 2006
Clinicopathologic and genetic analysis of siblings with NF1 and adult-onset gliomasSubramanian Hariharan, John E Donahue, Cecial Garre, et al.
Cerebrovascular Diseases (Basel, Switzerland)|January 7, 2004
Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke?Pinky Agarwal, Sanjeev Kumar, Subramanian Hariharan, et al.
Current Medical Research and Opinion|July 13, 2016
The effect of information on preferences for treatments of metastatic renal cell carcinomaCarol Mansfield, Sandy Srinivas, Connie Chen, et al.
Journal of Neurosurgery|August 21, 2002
Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningiomaWarren P Mason, Fred Gentili, David R Macdonald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2013
Randomized phase III trial of temsirolimus and bevacizumab versus interferon alfa and bevacizumab in metastatic renal cell carcinoma: INTORACT trialBrian I Rini, Joaquim Bellmunt, Jill Clancy, et al.
Oncoimmunology|November 11, 2017
Immune evasion mechanisms and immune checkpoint inhibition in advanced merkel cell carcinomaDirk Schadendorf, Paul Nghiem, Shailender Bhatia, et al.
Pageof 4